Peripheral nerve injuries can happen to anyone and impact quality of life. More than 1.4 million Americans will experience a nerve injury this year and roughly 900,000 will require a surgical intervention. The need for nerve repair options is paramount.
Further, a report by Magellan Medical Technology Consultants shows that the US transected peripheral nerve repair market alone exceeds $1.6 billion.
AxoGen is the only company dedicated to peripheral nerve repair solutions and a pioneer in the regenerative medicine market with a portfolio of products for peripheral nerve reconstruction.
Our technologies – Avance® Nerve Graft, AxoGuard® Nerve Connector and AxoGuard® Nerve Protector – provide an option for surgeons to reconstruct injured nerves without the comorbidities associated with an additional surgical site. Further, they offer surgeons an opportunity to protect compressed nerves or reconstruct injured nerves. Our technologies are used by several surgical specialties and in peripheral nerves throughout the body.
For example, many US surgeons are offering their patients the option of Avance® Nerve Graft – a processed human nerve allograft offering the benefits of reconstruction with human peripheral nerve without the cost, time and physical deficits associated with harvesting the patient’s own tissue.
Analysis of recent implantations of Avance® Nerve Graft across thousands of repairs of small to large gaps in peripheral nerve, reflects diverse clinical application across nerve function, body area and nerve type.1
For more information on the US Peripheral Nerve Repair Market, read this report.